5-Methoxytryptamine: stimulation of 5-HT receptors mediating the rat hyperactivity syndrome and blood platelet aggregation.
D008735:5-Methoxytryptamine / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000494:pharmacology; D007700:Kinetics; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D018377:Neurotransmitter Agents / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011804:Quinolines / Q000494:pharmacology; D051381:Rats; D011985:Receptors, Serotonin / Q000187:drug effects*; D014191:Tranylcypromine / Q000494:pharmacology; D014363:Tryptamines / Q000494:pharmacology*
D018377:Neurotransmitter Agents; D010879:Piperazines; D011804:Quinolines; D011985:Receptors, Serotonin; D014363:Tryptamines; D014191:Tranylcypromine; D008735:5-Methoxytryptamine; D008238:Lysergic Acid Diethylamide; D006220:Haloperidol